US2005164256A1PendingUtilityA1
Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor
Est. expiryApr 15, 2018(expired)· nominal 20-yr term from priority
A61K 38/00C07K 14/4702
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions for treating a congenital heart disease and methods and compositions for prognosing or diagnosing a congenital heart disease in a subject are disclosed.
Claims
exact text as granted — not AI-modified1 . A method for treating or preventing the development of a congenital heart disease in a subject, comprising administering to the subject an effective amount of an FKHL 7 therapeutic.
2 - 10 . (canceled)Join the waitlist — get patent alerts
Track US2005164256A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.